Janssen Pharmaceutica (Johnson & Johnson)

Janssen Pharmaceuticals is a pharmaceutical company headquartered in Beerse, Belgium, and owned by Johnson & Johnson.

In 1961, Janssen Pharmaceuticals became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development, which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer.

Consultancy and engineering for pharma

FPC Risk has an umbrella contract with Janssen Pharmaceutica and Johnson & Johnson worldwide responsible for the various consultancy and engineering projects, covering amongst others:

  • Project management, consultancy and engineering services for implementation of life and fire safety systems at existing and new Janssen Pharmaceutica plants in Beerse and Geel
  • Consultancy and engineering assistance during design of fire detection/protection systems for new plants in Greece and China
  • Consultancy services to negotiate the required fire protection requirements with and to obtain approvals from the insurance company (FM-Global)
  • Verify compliance with local safety and environmental directives and laws
  • Assistance to JNJ WWERE on various projects
  • Fire risk screening of JNJ buildings
  • Upgrading and development of Janssen Pharmaceutica’s in-house safety and engineering standards
  • Risk analysis studies
  • Pre-Incident plan development
  • Business Continuity Planning for 6 sites in Belgium
  • Training & exercising of crisis management & emergency response teams
  • Assistant to purchase department regarding procurement
  • Testing and commissioning of fire safety systems
  • Renegotiation with the insurer and local government



Other Pharmaceutical & Medical references

Other references